SCHEMBL29565658

SCHEMBL29565658

O=C(COCc1ccccc1)c1c(O)cc(OCc2ccccc2)cc1OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
MAOB P27338 3/20 0.47
SLC5A1 P13866 2/20 0.46
SLC5A2 P31639 2/20 0.46
PTPN1 P18031 1/20 0.45
PARP10 Q53GL7 1/20 0.44
MCL1 Q07820 2/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
PTGS1 P23219 1/20 0.44
SLC6A2 P23975 1/20 0.44
CYP2C19 P33261 1/20 0.44
PTGS2 P35354 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HIF1A Q16665 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
NR4A2 P43354 2/20 0.43
NR4A1 P22736 1/20 0.43
NR4A3 Q92570 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23422279 1.00 MEN1 (0.49) MEN1KMT2AMAOBSLC5A1SLC5A2
SCHEMBL25021784 0.93 MEN1 (0.53) MEN1KMT2AMAOBPTPN1PARP10
SCHEMBL31031177 0.84 KMT2A (0.47) MEN1KMT2AMAOBPTPN1PARP10
SCHEMBL29565255 0.82 PPARG (0.50) MEN1KMT2AMAOBLMNASLC6A2
SCHEMBL658101 0.82 MAOB (0.61) MEN1KMT2AMAOBSLC5A1SLC5A2
SCHEMBL30141054 0.82 MAOB (0.61) MEN1KMT2AMAOBSLC5A1SLC5A2
SCHEMBL9218086 0.81 SLC5A1 (0.61) MEN1KMT2ASLC5A1SLC5A2PTPN1
SCHEMBL11739156 0.81 MAOB (0.59) MEN1KMT2AMAOBPTPN1PARP10
SCHEMBL4273295 0.81 FFAR1 (0.60) MEN1KMT2ASLC5A1SLC5A2LMNA
SCHEMBL2951462 0.79 MEN1 (0.65) MEN1KMT2AMAOBPARP10MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114981263-B Novel quercetin redox derivatives and use thereof as BET inhibitors 贝诺生物有限公司 2024-12-24 CN disclosed
US-20240254135-A1 POLYPHENOL COMPOUNDS EPIRIUM BIO INC (US) 2024-08-01 US disclosed
CN-114981263-A Novel quercetin redox derivatives and use thereof as BET inhibitors 贝诺生物有限公司 2022-08-30 CN disclosed
CN-114539044-A Dehydrated icaritin intermediate compound 鲁南制药集团股份有限公司 2022-05-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240254135-A1 POLYPHENOL COMPOUNDS COMT, MAPT, PPARG MEN1 4436/4885KMT2A 2933/4885MAOB 1155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.